Some people lose far more weight than others on GLP-1s like Wegovy. Here’s why.

Emerging research shows there are ‘super-responders’ to GLP-1 drugs, and others who don’t respond at all.

Summary aggregated from MarketWatch's public RSS feed. The full reporting belongs to MarketWatch — please read it on their site.